Both in Pharmaceuticals
Pacira BioSciences vs Stoke Therapeutics
Over the past year PCRX returned +63.1% and STOK returned −25.8%; their daily moves had a correlation of 0.13.
PCRX +63.1% STOK −25.8%Growth of $1, one year, split-adjusted
| Metric | PCRX | STOK |
|---|---|---|
| Price | $36.31 | $22.50 |
| Market cap | $1.45B | $1.45B |
| Today | −0.11% | −6.83% |
| 1 month | +47.1% | −24.0% |
| 6 months | +52.9% | −37.3% |
| Year to date | +40.3% | −29.1% |
| 1 year | +62.5% | −25.5% |
| Revenue growth (YoY) | +6.2% | −32.5% |
| Gross margin | 77.0% | 100.0% |
| Net margin | 2.4% | −660.8% |
| P/E (TTM) | 99.0× | — |
| Price / sales | 1.9× | 52.6× |
| Net cash | -$112.1M | $292.8M |
| Dividend yield | — | — |
| Volatility (60d) | 82.8% | 46.5% |
| Short % of float | 21.2% | 23.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).